Furthermore, the use of biologics such as tumor necrosis factor-α (TNF-α) inhibitors in IBD can lead to decreased apoptosis of plasma cells, thus setting the stage for the development of MM [7]. The gene discussed is TNF; the disease is inflammatory bowel disease.